Gene · 6423
Papers2,833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,833
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical applications and perspectives of circulating tumor DNA in gastric cancer. | Cancer Cell Int | 2024 | 38184573 | PubTator, text mining | PubMed |
| Circulating cell-free DNA methylation patterns as non-invasive biomarkers to monitor colorectal cancer treatment efficacy without referencing primary site mutation profiles. | Mol Cancer | 2024 | 38172877 | PubTator, text mining | PubMed |
| Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis. | Nat Commun | 2024 | 38172207 | PubTator, text mining | PubMed |
| Multiscale spatial mapping of cell populations across anatomical sites in healthy human skin and basal cell carcinoma. | Proc Natl Acad Sci U S A | 2024 | 38165934 | PubTator, text mining | PubMed |
| Fibroblast Subpopulations in Systemic Sclerosis: Functional Implications of Individual Subpopulations and Correlations with Clinical Features. | J Invest Dermatol | 2024 | 38147960 | PubTator, text mining | PubMed |
| Whole-transcriptome defines novel glucose metabolic subtypes in colorectal cancer. | J Cell Mol Med | 2024 | 38116696 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals Hippo signaling as a driver of fibrosis in hidradenitis suppurativa. | J Clin Invest | 2024 | 38051587 | PubTator, text mining | PubMed |
| Machine learning-derived identification of prognostic signature for improving prognosis and drug response in patients with ovarian cancer. | J Cell Mol Med | 2024 | 37994489 | PubTator, text mining | PubMed |
| Sfrp2 promotes renal dysfunction of diabetic kidney disease via modulating Fzd5-induced cytosolic calcium ion concentration and CaMKII/Mek/Erk pathway in mesangial cells. | Biochim Biophys Acta Mol Basis Dis | 2024 | 37951508 | PubTator, text mining | PubMed |
| Acetylation and deacetylation of histone in adipocyte differentiation and the potential significance in cancer. | Transl Oncol | 2024 | 37935080 | PubTator, text mining | PubMed |
| DNA methylation drives a new path in gastric cancer early detection: Current impact and prospects. | Genes Dis | 2024 | 37692483 | PubTator, text mining | PubMed |
| WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities. | Genes Dis | 2024 | 37692481 | PubTator, text mining | PubMed |
| Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy. | Aging Cell | 2024 | 37475161 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Derived from Dental Tissues-Related lncRNAs: A New Regulator in Osteogenic Differentiation. | J Tissue Eng Regen Med | 2023 | 40226409 | PubTator, text mining | PubMed |
| High-accuracy prediction of colorectal cancer chemotherapy efficacy using machine learning applied to gene expression data. | Front Physiol | 2023 | 38304289 | PubTator, text mining | PubMed |
| The importance of cancer-associated fibroblasts in targeted therapies and drug resistance in breast cancer. | Front Oncol | 2023 | 38273859 | PubTator, text mining | PubMed |
| Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications. | Front Immunol | 2023 | 38268926 | PubTator, text mining | PubMed |
| Personalization of Therapy in High-Grade Serous Tubo-Ovarian Cancer-The Possibility or the Necessity? | J Pers Med | 2023 | 38248751 | PubTator, text mining | PubMed |
| Current Research on Molecular Biomarkers for Colorectal Cancer in Stool Samples. | Biology (Basel) | 2023 | 38248446 | PubTator, text mining | PubMed |
| Expression of secreted frizzled-related proteins in acute aortic dissection patients and the effects on prognosis. | Front Cardiovasc Med | 2023 | 38188253 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6423/papers?page=9